Janssen Biotech and Samsung Bioepis jointly requested that Janssen’s patent infringement case be dismissed following the Supreme Court’s ruling earlier this year on the biosimilar approval process. The New Jersey…
The chief administrative law judge of the PTO’s Patent Trial and Appeal Board issued guidance to holders on how to amend their patents after being challenged with an inter partes…
A Philadelphia jury found Bayer and Johnson & Johnson liable for the injuries of a woman prescribed their prescription blood thinner Xarelto, following three consecutive victories for the drugmakers in…
For more efficient development of treatments for pediatric rare diseases, sponsors can implement controlled, multi-arm, multi-company clinical trials, according to a new draft guidance that the FDA says could help…
The FDA’s chief counsel said the agency is examining the legal circumstances where a company’s senior personnel and management could be held not only civilly responsible, but also criminally responsible…
According to the report, Isaly made lewd comments to female employees, subjected them to pornographic images and made "pervasive sexist comments." Source: BioSpace
The move is welcome news for Prime Minister Theresa May, who has struggled to win over large sections of industry as Britain prepares to leave the European Union. Source: BioSpace
As 2018 winds down, it's not over for some biopharma companies. Source: BioSpace
Cox takes over for Vital Therapies CEO Terry Winters who will step down from the Vital Therapies Board and become a consultant to the company. Source: BioSpace
Under the deal, Carmot will use its lead-identification technology to identify and advance novel drug leads for Parkinson's disease and other disease areas. Source: BioSpace